Go to Page # Page of 21

BTG Strategy, Development, Building Value

Description: UBS Global Life Sciences Conference, Strategy to deliver sustainable profitability, Leveraging our new US commercial operations, Varisolve varicose veins, Voraxaze finalizing BLA submission, BGC20-0134 (Pleneva) Phase IIa progress, OncoGel phase IIb progress, Future value drivers in licensed pipeline, Robust business model, Building a major specialty pharmaceuticals business
Views: 2383
Domain: Business
Category: Companies
UBS Gl b l Lif S i Global Life Sciences C f Conference
September 2010

Forward-looking statements

This presentation and information communicated verbally to you may contain certain projections and other forward-looking statements with respect to the financial condition condition, results of operations, businesses and prospects of BTG plc ("BTG"). These statements are based on current expectation ... See more

Recent Presentations

Barbara Dirks
27 June, 2019

Financial Services in Turkey

Banking & financial intermediary, capital markets, insurance, competitive landscape are basic financial services in Turkey. Turkey’s financial markets have been in a constant state

Invest In Turkey
26 June, 2019
Michel Favre
25 June, 2019